Preliminary evaluation on the anticancer activities of 4d, 4h and 4i on HepG2 cancer cell lines.
Compound | 200 μg mL−1 | 100 μg mL−1 | 50 μg mL−1 | |||
---|---|---|---|---|---|---|
Cell death | Cell death | Cell death | ||||
% | Mean ± S.D. | % | Mean ± S.D. | % | Mean ± S.D. | |
4d | 67.40 | 0.325 ± 0.018 | 30.93 | 0.691 ± 0.062 | 16.12 | 0.838 ± 0.040 |
4h | 59.74 | 0.402 ± 0.014 | 30.64 | 0.693 ± 0.028 | 20.57 | 0.794 ± 0.028 |
4i | 79.30 | 0.209 ± 0.040 | 70.40 | 0.474 ± 0.056 | 44.08 | 0.559 ± 0.003 |